Back
Air Liquide SA Vs. Sarepta Therapeutics Industry Stock Comparison
Sell
42
AIQUY
Air Liquide SA
Last Price:
$41.58
Seasonality Move:
3.05%
Sell
44
SRPT
Sarepta Therapeutics
Last Price:
$37.90
Seasonality Move:
2.85%
Sell
42
Air Liquide SA (AIQUY)
is a Sell
Is Air Liquide SA a Buy, Sell or Hold?
-
The current Air Liquide SA [AIQUY] share price is $41.58. The Score for AIQUY is 42, which is 16% below its historic median score of 50, and infers higher risk than normal.
-
AIQUY is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
44
Sarepta Therapeutics (SRPT)
is a Sell
Is Sarepta Therapeutics a Buy, Sell or Hold?
-
The current Sarepta Therapeutics [SRPT] share price is $37.90. The Score for SRPT is 44, which is 12% below its historic median score of 50, and infers higher risk than normal.
-
SRPT is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
AIQUY Stock Price Chart
What is Air Liquide SA's stock price today?
-
The Air Liquide SA share price today is $41.58The current trend is moderately bullish and AIQUY is experiencing slight buying pressure.
SRPT Stock Price Chart
What is Sarepta Therapeutics's stock price today?
-
The Sarepta Therapeutics share price today is $37.90Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SRPT is experiencing slight selling pressure.
AIQUY Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.62 | Buy |
Relative Strength Index (14 RSI): | 58.43 | Buy |
Chaikin Money Flow: | 55094 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (40.31 - 41.71) | Buy |
Bollinger Bands (100): | (34.25 - 40.37) | Buy |
SRPT Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -6.42 | Sell |
Relative Strength Index (14 RSI): | 31.09 | Sell |
Chaikin Money Flow: | -666857 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (36.33 - 59.83) | Sell |
Bollinger Bands (100): | (54.34 - 115.94) | Sell |
AIQUY Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 41.59 | Sell |
20-day SMA: | 41.26 | Buy |
50-day SMA: | 39.65 | Buy |
200-day SMA: | 36.53 | Buy |
8-day EMA: | 41.57 | Buy |
20-day EMA: | 41.07 | Buy |
50-day EMA: | 39.77 | Buy |
200-day EMA: | 37.04 | Buy |
SRPT Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 37.76 | Buy |
20-day SMA: | 45.28 | Sell |
50-day SMA: | 56.86 | Sell |
200-day SMA: | 105.88 | Sell |
8-day EMA: | 38.9 | Sell |
20-day EMA: | 43.83 | Sell |
50-day EMA: | 58.25 | Sell |
200-day EMA: | 94.77 | Sell |
Air Liquide SA Earnings Growth & AIQUY Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.19 per share, and an increase next year of $0.25 per share.
Sarepta Therapeutics Earnings Growth & SRPT Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.74 per share, an increase next quarter of $0.95 per share, a decrease this year of $3.92 per share, and an increase next year of $7.74 per share.
Air Liquide SA Technical Analysis
May 12 | May 13 | May 14 | May 15 | May 16 | May 19 | May 20 | May 21 | May 22 | May 23 | |
---|---|---|---|---|---|---|---|---|---|---|
May | ||||||||||
12 | 13 | 14 | 15 | 16 | 19 | 20 | 21 | 22 | 23 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Sarepta Therapeutics Technical Analysis
May 12 | May 13 | May 14 | May 15 | May 16 | May 19 | May 20 | May 21 | May 22 | May 23 | |
---|---|---|---|---|---|---|---|---|---|---|
May | ||||||||||
12 | 13 | 14 | 15 | 16 | 19 | 20 | 21 | 22 | 23 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |